Anna Tenstam

Anna Tenstam currently serves as the CEO and board member of OXAGON AB since August 2022, and holds the position of Styrelseordförande at DAYA since September 2023. Anna Tenstam is also a board member at Medicortex Finland Oy and Optomed Plc, with ongoing roles since January 2022 and June 2020, respectively. As a self-employed Senior Advisor since 2006, Anna Tenstam has collaborated with various organizations including Shaare Zedek Scientific Ltd, Patients Pending/Timsulin, Stylefindr, and TFS. From June 2023 to December 2023, Anna Tenstam worked as the Chief Commercial Officer at THiS Group AB (publ). Previous significant roles include Partner/Board member, CEO, and Chairman at Sue Ellen Investments from 2019 to August 2023, and board member and senior advisor at Peptonic Medical AB until May 2022. Anna Tenstam's educational background includes a Master of Business Administration from IMD, an EMP from Stockholm School of Business, and a Master of Science from Uppsala University.